JPWO2023166322A5 - - Google Patents
Info
- Publication number
- JPWO2023166322A5 JPWO2023166322A5 JP2024552013A JP2024552013A JPWO2023166322A5 JP WO2023166322 A5 JPWO2023166322 A5 JP WO2023166322A5 JP 2024552013 A JP2024552013 A JP 2024552013A JP 2024552013 A JP2024552013 A JP 2024552013A JP WO2023166322 A5 JPWO2023166322 A5 JP WO2023166322A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- formula
- integer
- antibody conjugate
- moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2203070.4A GB202203070D0 (en) | 2022-03-04 | 2022-03-04 | Anti-canag antibody conjugate |
| GB2203070.4 | 2022-03-04 | ||
| PCT/GB2023/050522 WO2023166322A1 (en) | 2022-03-04 | 2023-03-06 | Anti-canag antibody conjugate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025509152A JP2025509152A (ja) | 2025-04-11 |
| JP2025509152A5 JP2025509152A5 (https=) | 2026-01-26 |
| JPWO2023166322A5 true JPWO2023166322A5 (https=) | 2026-01-26 |
Family
ID=81175257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552013A Pending JP2025509152A (ja) | 2022-03-04 | 2023-03-06 | 抗ＣａｎＡｇ抗体複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250213711A1 (https=) |
| EP (1) | EP4486392A1 (https=) |
| JP (1) | JP2025509152A (https=) |
| KR (1) | KR20240163656A (https=) |
| CN (1) | CN119136841A (https=) |
| AU (1) | AU2023229192A1 (https=) |
| GB (1) | GB202203070D0 (https=) |
| IL (1) | IL315428A (https=) |
| WO (1) | WO2023166322A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| GB202313214D0 (en) * | 2023-08-30 | 2023-10-11 | Iksuda Therapeutics Ltd | Co-administration of antibody-drug conjugate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE045348T2 (hu) | 2011-05-08 | 2019-12-30 | Legochem Biosciences Inc | Fehérje-hatóanyag konjugátumok és eljárás elõállításukra |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| HRP20240795T1 (hr) | 2015-11-25 | 2024-09-13 | Ligachem Biosciences Inc. | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima |
| KR102847350B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 |
| MX2019011655A (es) * | 2017-03-29 | 2019-12-19 | Legochem Biosciences Inc | Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este. |
| WO2018182341A1 (ko) | 2017-03-29 | 2018-10-04 | 주식회사 레고켐 바이오사이언스 | 피롤로벤조디아제핀 이량체 전구체 및 이의 리간드-링커 접합체 화합물 |
| EP3950061A4 (en) * | 2019-03-25 | 2022-11-16 | Daiichi Sankyo Company, Limited | ANTIBODY PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE |
-
2022
- 2022-03-04 GB GBGB2203070.4A patent/GB202203070D0/en not_active Ceased
-
2023
- 2023-03-06 US US18/843,659 patent/US20250213711A1/en active Pending
- 2023-03-06 WO PCT/GB2023/050522 patent/WO2023166322A1/en not_active Ceased
- 2023-03-06 IL IL315428A patent/IL315428A/en unknown
- 2023-03-06 EP EP23711533.2A patent/EP4486392A1/en active Pending
- 2023-03-06 AU AU2023229192A patent/AU2023229192A1/en active Pending
- 2023-03-06 CN CN202380037771.5A patent/CN119136841A/zh active Pending
- 2023-03-06 JP JP2024552013A patent/JP2025509152A/ja active Pending
- 2023-03-06 KR KR1020247032787A patent/KR20240163656A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025041725A5 (https=) | ||
| JPWO2020122034A5 (https=) | ||
| JP2025113404A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2023098946A5 (https=) | ||
| JP2022103282A (ja) | 親水性抗体－薬物コンジュゲート | |
| JPWO2020031936A5 (https=) | ||
| JP2008546792A5 (https=) | ||
| JP2017537893A5 (https=) | ||
| JPWO2022102695A5 (https=) | ||
| EP4460330A1 (en) | Conjugates, compositions and methods of use | |
| JP2019534889A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JP2015526435A (ja) | 抗体成分と血液脳関門を通過するポリペプチドと細胞毒とを含むコンジュゲート | |
| JP2020534300A5 (https=) | ||
| JP2012509344A5 (https=) | ||
| JP2024056791A5 (https=) | ||
| CN108601952A (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JPWO2022102634A5 (https=) | ||
| JPWO2021260579A5 (https=) | ||
| JPWO2019191728A5 (https=) | ||
| JPWO2023166322A5 (https=) | ||
| JP2022543022A (ja) | 抗体‐ポリマー複合体 | |
| JP5289310B2 (ja) | 微小管破壊剤及びそれを含有する癌細胞増殖抑制剤 |